Minze Health announced that it entered into a three-year agreement with Medtronic to commercialize its overactive bladder ...
HealthShots on MSN
UTI or just period changes? Know what causes frequent urination during menstruation
Have you ever noticed yourself making extra trips to the bathroom during your period and wondered if something is wrong? Many ...
Minze Health NV signed a three-year agreement with Medtronic plc to bring its Minze Diary Pod, an app-controlled automated ...
Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
Welltica+ on MSN
Tiny implant eliminates bladder cancer in 82% of patients
A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...
The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback